Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kamada Ltd. - Ordinary Shares (NQ:KMDA)

7.890 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 900
Open 7.890
Bid (Size) 7.820 (100)
Ask (Size) 7.860 (400)
Prev. Close 7.890
Today's Range 7.890 - 7.890
52wk Range 6.500 - 9.350
Shares Outstanding 44,742,963
Dividend Yield 3.17%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Kamada (KMDA) Q2 2026 Earnings Call Transcript ↗
KEDRAB sales and distribution expansion drive record revenue and EBITDA growth. 
Via The Motley Fool
Topics Earnings
News headline image
Kamada Q2 Earnings Call Highlights ↗
Kamada (NASDAQ:KMDA) reported record revenue and adjusted EBITDA for the second quarter and first half of 2026, driven by higher sales of its specialty plasma-derived products, including KEDRAB,... 
Via MarketBeat
Topics Earnings

Performance

YTD
+12.2%
+12.2%
1 Month
+11.3%
+11.3%
3 Month
+0.3%
+0.3%
6 Month
-10.8%
-10.8%
1 Year
+9.0%
+9.0%

More News

Read More
News headline image
Kamada (KMDA) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Kamada Ltd (NASDAQ:KMDA) Reports Record 2025 Results Despite Q4 Earnings Miss ↗
Via Chartmill
News headline image
Earnings Scheduled For November 10, 2025 ↗
Via Benzinga
News headline image
An Overview of Kamada's Earnings ↗
Via Benzinga
News headline image
An Overview of Kamada's Earnings ↗
Via Benzinga
News headline image
Kamada Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Kamada Targets 13% Revenue Growth And 23% Adjusted EBITDA Growth In 2026 Driven By Its Diverse Commercial Portfolio
Via NewMediaWire
News headline image
Kamada Targets 13% Revenue Growth And 23% Adjusted EBITDA Growth In 2026 Driven By Its Diverse Commercial Portfolio
Via TheNewswire.com
News headline image
Kamada Reports Strongest Quarter For The Year In Q3, With Over 30% Profitability Increase Year-Over-Year
Via NewMediaWire
News headline image
Earnings Preview For Kamada ↗
Via Benzinga
News headline image
Kamada Reports Strongest Quarter For The Year In Q3, With Over 30% Profitability Increase Year-Over-Year
Via TheNewswire.com
News headline image
Kamada (KMDA) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
KAMADA LTD (NASDAQ:KMDA) Reports Mixed Q3 2025 Results with Revenue Beat and Pre-Market Surge ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Via Benzinga
News headline image
KAMADA LTD (NASDAQ:KMDA) Reports Mixed Q2 2025 Earnings with Strong EPS Beat and Raised Profitability Guidance ↗
Via Chartmill
News headline image
Kamada Q1 Results: Double-Digit Growth, Company Reiterates Guidance As It Hits Multiple Milestones Including Plasma Business Expansion
Via NewMediaWire
News headline image
Kamada Q1 Results: Double-Digit Growth, Company Reiterates Guidance As It Hits Multiple Milestones Including Plasma Business Expansion
Via TheNewswire.com
News headline image
Kamada Wants To Do More For Organ Transplant Patients, Increases Efforts To Build Awareness Of Its CMV Treatment CYTOGAM
Via NewMediaWire
News headline image
Earnings Scheduled For August 13, 2025 ↗
Via Benzinga
News headline image
Kamada Wants To Do More For Organ Transplant Patients, Increases Efforts To Build Awareness Of Its CMV Treatment CYTOGAM
Via TheNewswire.com
News headline image
Kamada Expects Third Plasma Collection Site To Support Its Hyper-Immune Plasma Needs And Add Up To $10M In Annual Revenue At Full Capacity
Via NewMediaWire
News headline image
Kamada Expects Third Plasma Collection Site To Support Its Hyper-Immune Plasma Needs And Add Up To $10M In Annual Revenue At Full Capacity
Via TheNewswire.com
News headline image
Earnings Scheduled For May 14, 2025 ↗
Via Benzinga

Frequently Asked Questions

Is Kamada Ltd. - Ordinary Shares publicly traded?
Yes, Kamada Ltd. - Ordinary Shares is publicly traded.
What exchange does Kamada Ltd. - Ordinary Shares trade on?
Kamada Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Kamada Ltd. - Ordinary Shares?
The ticker symbol for Kamada Ltd. - Ordinary Shares is KMDA on the Nasdaq Stock Market
What is the current price of Kamada Ltd. - Ordinary Shares?
The current price of Kamada Ltd. - Ordinary Shares is 7.890
When was Kamada Ltd. - Ordinary Shares last traded?
The last trade of Kamada Ltd. - Ordinary Shares was at 08/19/26 04:00 PM ET
What is the market capitalization of Kamada Ltd. - Ordinary Shares?
The market capitalization of Kamada Ltd. - Ordinary Shares is 353.02M
How many shares of Kamada Ltd. - Ordinary Shares are outstanding?
Kamada Ltd. - Ordinary Shares has 353M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.